Proposed clinical pathway for managing patients with NELM based on the authors’ institutional experience. NELM, neuroendocrine liver metastases; PNET, pancreatic neuroendocrine tumor; TAE, transarterial embolization; XRT, radiation therapy; PRRT; peptide receptor radionuclide therapy; SSAs, somatostatin analogs.